stroke
-
Thomas Smeenk Discusses the Intersection of Hemostemix’s NCP Treatment and Elon Musk’s Neuralink
In this InvestorIntel interview, Tracy Weslosky talks with Hemostemix Inc.’s (TSXV: HEM | OTCQB: HMTXF) Co-Founder, CEO, and President…
-
The EYES have it, Early Stage Detection of Diabetes and Cardiovascular Disease
Using Artificial Intelligence (AI) to better image and analyze the retina of the eye to detect early stage…
-
Eyes on DIAGNOS as commercialization gains momentum
The best time to buy an emerging company is when it begins commercialization. At this stage all the…
-
Diagnos’ André Larente on Entering the DACH and Central European Healthcare Market
In a recent InvestorIntel interview, Tracy Weslosky spoke with André Larente President of Diagnos Inc. (TSXV: ADK |…
